Editorial: New insights into inflammation driven autoimmune skin disorders: trends and challenges

• by Manoj Kumar Tembhre, Alpana Sharma, Pankaj Dipankar, Shanid Mohiyuddin, Mohammad Tarique, Suneel Kumar

• July 7, 2026

Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at Week 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two Phase III Trials

• by Maria Esposito, Juan Manuel Morón-Ocaña, Aditya K. Gupta, Jordi Galván, Ayoub Bentohami, Frank Freischläger

• July 1, 2026

Guselkumab Shows Psoriasis Benefit in Darker Skin Tones

Randomized trial suggests sustained clearance across darker skin tones.

• by Andrea Surnit

• May 14, 2026

• 3 min

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

• by Kathryn Wighton

• May 20, 2026

• 5 min